Abstract

Social distancing as a measure to stop the spread of COVID-19 has drastically increased the need for technology-based mental health services. However, resources for the psychological assessment and treatment of the public are extremely limited. Over the past two decades, advances in information and communication technology (ICT) have facilitated technologybased- mental health services, which are deemed the most prominent alternative to traditional face-to-face service delivery amid the pandemic. Both digital phenotyping and digital therapeutics have recently been introduced and actively investigated. In this study, existing research in digital phenotyping and digital therapeutics for autism spectrum disorder was reviewed as a sample to clarify the status of its field applications. Although the development of digital phenotyping is in its early stages, digital therapeutics have been actively and successfully implemented in the treatment field. Given the increasing need for mental health services after the COVID-19 outbreak, change is no longer optional. Thus, preparation for a new technology- based assessment and treatment framework is necessary.